ClinicalTrialsFinder

FGFR3 Gene Mutation Clinical Trials in Chicago Ridge, Illinois

1 recruitingChicago Ridge, Illinois

Showing 1–1 of 1 trials

Recruiting
Phase 2

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Low-grade NMIBCFGFR Gene AmplificationFGFR Gene Alterations+3 more
Tyra Biosciences, Inc90 enrolled35 locationsNCT06995677